Neoadjuvant immunotherapy improves outcomes in high-risk melanoma patients.

Published Date: 02 Mar 2023

High-risk melanoma patients who received the drug pembrolizumab before or after surgery to remove the cancer had a higher risk of developing melanoma than those who did not have a similar condition that eliminated cancer cells.

Read Full News

Latest News

The Restorative Power of ‘Sacred Moments’ in Medicine

Deep human connection can be a potent antidote to burnout. Here’s how to cultivate meaning in an increasingly rushed healthcare system.

US FDA Approves Outlook Therapeutics' Eye Disease Drug

Outlook Therapeutics said on Friday the U.S. Food and Drug Administration has approved its drug for ⁠a type of eye disease that can cause vision loss.

Nasal IgA Protects Against H1N1, SARS-CoV-2 Infections

High baseline nasal IgA, not serum IgG, was linked to lower risk for influenza A H1N1 infection in a real-world study.

Punchlines and Pathology: The Secrets of Laughter Explained

A new review of data from patients with epilepsy describes two distinct neural networks, offering clinicians and patients a way to better understand laughter as a neurologic malfunction.

Gene Therapy Delivers Sustained Retinal Protection

People with age-related macular degeneration maintain vision and cut their need for supplemental injections by 90% 5 years after receiving gene therapy.

Online Harassment: Should Doctors Stay on Social Media?

Online harassment increasingly targets physicians who share evidence-based information, prompting calls for stronger institutional support and safer public engagement.

Todays Updates

Schizophrenia: Nighttime Light Tied to Metabolic Dysfunction

Higher vs lower nighttime light exposure is associated with increased risk for obesity, hypertension, and dyslipidemia in patients with schizophrenia, a study suggests.

Transperineal Biopsy IDs Active Surveillance Candidates

Transperineal 3D mapping biopsy may help select patients with low-risk prostate cancer who are most likely to fare well with active surveillance.

The Clues Hidden in Failed Prostate Cancer Trials

Many experts consider prostate cancer one of immunotherapy’s biggest disappointments. But a handful of patients don’t fit that narrative, and researchers are starting to uncover why.

Todays Updates

Schizophrenia: Nighttime Light Tied to Metabolic Dysfunction

Higher vs lower nighttime light exposure is associated with increased risk for obesity, hypertension, and dyslipidemia in patients with schizophrenia, a study suggests.

Transperineal Biopsy IDs Active Surveillance Candidates

Transperineal 3D mapping biopsy may help select patients with low-risk prostate cancer who are most likely to fare well with active surveillance.

The Clues Hidden in Failed Prostate Cancer Trials

Many experts consider prostate cancer one of immunotherapy’s biggest disappointments. But a handful of patients don’t fit that narrative, and researchers are starting to uncover why.

Latest News

Deep human connection can be a potent antidote to burnout. Here’s how to cultivate meaning in an increasingly rushed healthcare system.

Outlook Therapeutics said on Friday the U.S. Food and Drug Administration has approved its drug for ⁠a type of eye disease that can cause vision loss.

High baseline nasal IgA, not serum IgG, was linked to lower risk for influenza A H1N1 infection in a real-world study.
HTTP error: 503HTTP error: 503HTTP error: 503

News All Time

HTTP error: 503HTTP error: 503

How to Teach Professionalism? Ditch the Deficiency Focus

Teaching professionalism in medical school is required, but how best to do it? Move beyond a deficiency focus, experts say. Emphasize positive examples of professionalism.

Anemia Leads List of Factors That Affect BLVR Failure

Recognizing the impact of comorbidities may guide patient selection and improve outcomes.
HTTP error: 503HTTP error: 503HTTP error: 503HTTP error: 503HTTP error: 503

RSV Preventive Strategies Tied to Fewer Bronchiolitis Cases

Administration of nirsevimab and RSV vaccination in pregnant women are tied to significant reductions in hospitalized days and oxygen requirements among infants with bronchiolitis.

Light Activity Pays Off for COPD Survival

New data show that patients need not exercise intensely to improve outcomes.

Initial Prescription Duration May Shape Benzodiazepine Use

Longer durations of initial prescriptions are associated with prolonged use of benzodiazepines compared with durations of 7 days or less, a large cohort study shows.

Alcohol’s Health Myth Is Over. How to Tell Patients

The science on alcohol has changed dramatically. Here’s how experts say physicians can explain why older advice no longer holds up — and counsel patients without judgment.

US House Committee Opens Investigation Into Merck, AbbVie China Drug Trials

The chair of the U.S. House Select Committee on China opened national security investigations into whether five drugmakers including Merck and AbbVie have been involved in...

Bepirovirsen Achieves Functional Cure in HBV Phase 3 Trial

In patients with chronic hepatitis B infection, bepirovirsen achieves significantly higher rates of functional cure than placebo after discontinuation of nucleoside or nucleotide analog therapy.

Retina Care Visits Reveal High BP in Adults With Diabetes

Many adults with diabetes have uncontrolled or previously undiagnosed high blood pressure during their routine visits to retina clinics, prompting referrals and urgent follow-up, a study finds.

Recommended News For You

Maintenance Rituximab Improves Survival in Elderly MRD-Negative MCL Patients.

Targeted First-Line Combo Approved for EGFR-Mutated Lung Cancer

WHO releases new R&D landscape analyses highlighting gaps and inequities in cancer research

Retifanlimab-Chemo Combo Boosts PFS in Advanced Squamous Cell Anal Cancer

Older Men Increasingly Overtreated for Prostate Cancer, Study Suggests

Transplantation Fails to Improve Survival in Mantle Cell Lymphoma

Enhanced access for patients with prostate cancer is provided by the new SPECT/CT technique, which demonstrates remarkable biomarker identification.

Recommended Articles For You

Bone Marrow Regenerative Capacity and Hematologic Recovery 

The Crucial Role of Antithrombin 3 in Preventing Blood Clots: A Comprehensive Guide 

The Truth About Marijuana and Its Effect on Mental Health  

Immuno-Oncology in Daily Practice: Transforming Cancer Care One Patient at a Time 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Doxorubicin-Trabectedin Strategy Boosts Survival in Challenging Sarcoma

2.

Mosunetuzumab in Follicular Lymphoma: Durable Responses and Manageable Safety

3.

Which Salvage Therapy Is Best for Recurrent Prostate Cancer?

4.

Belzutifan Plus Pembro Approved for Adjuvant RCC

5.

investigating radiation oncology applications of artificial general intelligence.

1.

Exploring the Causes and Treatments of Cysts: A Comprehensive Guide

2.

Hemophilia Beyond Boundaries: Unconventional Therapies in Bleeding Disorder Care

3.

Strategic Standards in Hematology for Specialists

4.

Iron Metabolism and Inflammatory Disorders: Mechanisms, Clinical Implications, and Therapeutic Approaches

5.

First-Line Immuno-Hematology Examinations: Essential Diagnostic Tools for Patient Care

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part I

2.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI

3.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part II

4.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part I

5.

Navigating the Complexities of Ph Negative ALL - Part XV

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot